Overview

A Phase 2A Trial of MM402 for Autism Spectrum Disorder

Status:
RECRUITING
Trial end date:
2027-08-01
Target enrollment:
Participant gender:
Summary
A Phase 2A Trial of MM402 Open-Label Study in Adults with Autism Spectrum Disorder
Phase:
PHASE2
Details
Lead Sponsor:
Mind Medicine, Inc.
Treatments:
N-Methyl-3,4-methylenedioxyamphetamine